
Laboratório de Desenvolvimento de Vacinas
Publicações de 2014
de Souza RD, Batista MT, Luiz WB, Cavalcante RC, Amorim JH, Bizerra RS, Martins EG, Ferreira LC. Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLoS One. 2014 Jan 27;9(1):e87454.
Acesse Aqui:
Amorim, Jaime Henrique ; ALVES, RÚBENS PRINCE DOS SANTOS ; BOSCARDIN, SILVIA BEATRIZ ; FERREIRA, LUÍS CARLOS DE SOUZA . The dengue virus non-structural 1 protein: Risks and benefits. Virus Research (Print), v. 181, p. 53-60, 2014.
Acesse Aqui:
Braga CJ, Rodrigues JF, Medina-Armenteros Y, Farinha-Arcieri LE, Ventura AM, Boscardin SB, Sbrogio-Almeida ME, Ferreira LC. Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant. Frontiers in immunology. 2014 Jan 7; 4:487.
Acesse Aqui:
Tavares Batista M, Souza RD, Paccez JD, Luiz WB, Ferreira EL, Cavalcante RC, Ferreira RC, Ferreira LC. Gut Adhesive Bacillus subtilis Spores as a Platform for Mucosal Delivery of Antigens. Infection and immunity. 2014 Apr;82(4):1414-23. Jan 13, 2014.
Acesse Aqui:
Alves RPS, Yang MJ, Batista MT and Ferreira LCS. Alzheimer's disease: is a vaccine possible?. Brazilian Journal of Medical and Biological Research. (2014) 47(6): 438-444
Acesse Aqui:
de Melo F. M.; Braga, C. J.; Pereira, F. V.; Maricato, J. T,; Origassa, C. S.;, Souza M. F.; Melo, A. C.; Silva, P; Tomaz, S. L.; Gimenes, K. P.; Scutti, J. A.; Juliano, M. A.; Zamboni, D. S, Câmara, N. O, Travassos, L. R; Ferreira, L. C.; Rodrigues, E. G. Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10. Immunology and cell biology. v.93(1):86-98. 2015.
Acesse Aqui:
Batista, M. T.; Souza, R. D.; Ferreira, E. L.; Robinette, R.; Crowley, P. J.; Rodrigues, J. F.; Brady, L. J.; Ferreira, L. C.; Ferreira, R. C. Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of theStreptococcus mutans P1 surface protein. Infection and immunity. 82(12):4978-88. 2014.
Acesse Aqui:
NIZARD, M.; DINIZ, M. O.; ROUSSEL, H.; TRAN, T.; FERREIRA, L. C. S.; BADOUAL, C.; TARTOUR, E. Mucosal vaccines. Human Vaccines & Immunotherapeutics, v. 10, p. 2175-2187, 2014.
Acesse Aqui:
Amorim, J. H.; Jesus, M. R.; Luiz, W. B.; Porchia, B. F.; Ferreira, R. C.; Servat, E. G.; Ghiringhelli, P. D.; Ferreira, L. C.; Bentancor, L. V. Role of bacteriophages in STEC infections: new implications for the design of prophylactic and treatment approaches. F1000 Research. v. 18;3:74. 2014.
Acesse Aqui:
Borin, T. F.; Zuccari, D. A.; Jardim-Perassi, B. V.; Ferreira, L.C.; Iskander, A.S.; Varma, N. R.; Shankar, A.; Guo, A. M.; Scicli, G. Arbab, A. S. HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice. PloS one. v. 30;9(12):e116247. 2014.
Acesse Aqui:
Hu, J. C.; Mathias-Santos, C.; Greene, C. J.; King-Lyons, N. D.; Rodrigues, J.F.; Hajishengallis, G.; Ferreira, L. C.; Connell, T. D. Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8+ T Cell Immunity to a Co-Administered Antigen. PLoS One. v. 23;9(12):e113978. 2014.
Acesse Aqui: